Status:
UNKNOWN
A Dose Ranging Study of Modafinil for Methamphetamine Dependence
Lead Sponsor:
California Pacific Medical Center Research Institute
Conditions:
Substance Dependence
Amphetamine Dependence
Eligibility:
All Genders
18-50 years
Phase:
PHASE2
Brief Summary
Patients treated for methamphetamine dependence have high rates of relapse, and no pharmacotherapy has yet been demonstrated to be efficacious. Modafinil (d, l-2-\[(diphenylmethyl)sulfinyl\]acetamide)...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age between 18 and 50 years
- Patient is agreeable to conditions of study and signs consent form
Exclusion
Key Trial Info
Start Date :
December 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2011
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT00630097
Start Date
December 1 2009
End Date
June 1 2011
Last Update
June 22 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CPMC
San Francisco, California, United States, 94110